Your browser doesn't support javascript.
The Challenge of Studying Long COVID: An Updated Review.
Zimmermann, Petra; Pittet, Laure F; Curtis, Nigel.
  • Zimmermann P; From the Faculty of Science and Medicine, University of Fribourg.
  • Pittet LF; Department of Paediatrics, Fribourg Hospital HFR, Fribourg, Switzerland.
  • Curtis N; Department of Paediatrics, The University of Melbourne.
Pediatr Infect Dis J ; 41(5): 424-426, 2022 05 01.
Article in English | MEDLINE | ID: covidwho-1788550
ABSTRACT
Accurately determining the risk of long COVID is challenging. Existing studies in children and adolescents have considerable limitations and distinguishing long-term SARS-CoV-2 infection-associated symptoms from pandemic-related symptoms is difficult. Over half of individuals in this age group, irrespective of COVID-19, report physical and psychologic symptoms, highlighting the impact of the pandemic. More robust data is needed to inform policy decisions.
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Type of study: Prognostic study Topics: Long Covid Limits: Adolescent / Child / Humans Language: English Journal: Pediatr Infect Dis J Journal subject: Communicable Diseases / Pediatrics Year: 2022 Document Type: Article

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Type of study: Prognostic study Topics: Long Covid Limits: Adolescent / Child / Humans Language: English Journal: Pediatr Infect Dis J Journal subject: Communicable Diseases / Pediatrics Year: 2022 Document Type: Article